Acesso livre
Acesso livre

Hematologia

Estudo randomizado | Mitapivate vs. placebo para deficiência de piruvatoquinase.

19 Abr, 2022 | 12:31h

Mitapivat versus Placebo for Pyruvate Kinase Deficiency – New England Journal of Medicine

Estudo de coorte | Tipo sanguíneo não O está associado a risco aumentado de tromboembolismo venoso em pacientes com câncer.

18 Abr, 2022 | 15:19h

ABO blood group type and risk of venous thromboembolism in patients with cancer – Blood Advances (link para o resumo – $ para o texto completo)

Revisão | Manifestações cutâneas da gamopatia monoclonal.

18 Abr, 2022 | 15:13h

Cutaneous manifestations of monoclonal gammopathy – Blood Cancer Journal

Revisão | Terapia de indução anterior à transplante autólogo de células-tronco no mieloma múltiplo recém-diagnosticado.

18 Abr, 2022 | 15:03h

Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update – Blood Cancer Journal

Diretrizes NCCN | Toxicidades relacionadas a terapia com CAR T Cells em pacientes com câncer.

12 Abr, 2022 | 12:31h

Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

Conteúdos relacionados:

Reviews: CAR T-Cell Therapy Toxicities and Side Effects

Reviews: CAR T-Cell Therapy Toxicities and Side Effects

Critical Care Management of Chimeric Antigen Receptor T Cell–related Toxicity. Be Aware and Prepared

Reviews: CAR T-Cell Therapy Toxicities and Side Effects

M-A | Padrões de trombose e desfecho clínico da trombocitopenia trombótica imune induzida por vacina contra COVID-19.

11 Abr, 2022 | 12:58h

Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis – International Journal of Infectious Diseases

Conteúdos relacionados:

Case series of Thrombosis with Thrombocytopenia Syndrome after Covid-19 vaccination in the US.

Review: Vaccine-induced immune thrombotic thrombocytopenia.

Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.

Clinical features of vaccine-induced immune thrombocytopenia and thrombosis.

Review: Clinical characteristics and pharmacological management of COVID-19 vaccine–induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis.

Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know.

Very rare cases of thrombosis with thrombocytopenia syndrome (TTS) after AstraZeneca vaccine: a global safety database analysis – the estimated rate of TTS after the first dose was 8.1 per million vaccinees; after the second dose, the estimated rate was 2.3 per million vaccinees. (vários artigos e fontes sobre o tema)

Estudo mostra risco aumentado de embolia pulmonar em até 110 dias após a COVID-19.

8 Abr, 2022 | 21:58h

Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study – The BMJ

Comunicado de imprensa: Study finds increased risk of serious blood clots up to six months after COVID-19 – BMJ

Editorial: Thromboembolism and bleeding after covid-19

Comentário: Covid: Blood clot risk higher for six months after having virus – BBC

M-A | Risco de recorrência em mulheres com tromboembolismo venoso relacionado ao uso de contraceptivos com estrogênio.

8 Abr, 2022 | 17:28h

Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: Systematic review and meta-analysis – Journal of Thrombosis and Haemostasis

Estudo randomizado | Eritropoietina não é benéfica para pacientes com lesão renal aguda.

8 Abr, 2022 | 17:02h

Erythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial – BMC Nephrology

Estudo antes-e-depois | Gestão de antibióticos em pacientes com neutropenia febril de alto risco reduziu o uso de carbapenêmicos e glicopeptídios e foi associada com melhores desfechos clínicos.

5 Abr, 2022 | 11:52h

Antimicrobial stewardship in high-risk febrile neutropenia patients – Antimicrobial Resistance & Infection Control

Conteúdos relacionados:

Safety and efficacy of antibiotic de-escalation and discontinuation in high-risk hematological patients with febrile neutropenia: a single-center experience.

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines – Annals of Oncology

 

Comentário do autor no Twitter (fio – clique para saber mais)

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.